7-146994128-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.403-49779C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.937 in 152,234 control chromosomes in the GnomAD database, including 66,931 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.94 ( 66931 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0800

Publications

2 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.403-49779C>T
intron
N/ANP_054860.1A0A090N7T7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.403-49779C>T
intron
N/AENSP00000354778.3Q9UHC6-1
CNTNAP2
ENST00000636561.1
TSL:5
n.306-49779C>T
intron
N/A
CNTNAP2
ENST00000636870.1
TSL:5
n.264+30973C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.937
AC:
142537
AN:
152116
Hom.:
66884
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.976
Gnomad AMI
AF:
0.984
Gnomad AMR
AF:
0.950
Gnomad ASJ
AF:
0.927
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.951
Gnomad FIN
AF:
0.924
Gnomad MID
AF:
0.883
Gnomad NFE
AF:
0.907
Gnomad OTH
AF:
0.943
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.937
AC:
142642
AN:
152234
Hom.:
66931
Cov.:
32
AF XY:
0.939
AC XY:
69828
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.975
AC:
40534
AN:
41560
American (AMR)
AF:
0.950
AC:
14515
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.927
AC:
3215
AN:
3470
East Asian (EAS)
AF:
0.999
AC:
5166
AN:
5172
South Asian (SAS)
AF:
0.951
AC:
4583
AN:
4818
European-Finnish (FIN)
AF:
0.924
AC:
9793
AN:
10596
Middle Eastern (MID)
AF:
0.874
AC:
257
AN:
294
European-Non Finnish (NFE)
AF:
0.907
AC:
61685
AN:
68016
Other (OTH)
AF:
0.944
AC:
1997
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
481
962
1442
1923
2404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.915
Hom.:
123869
Bravo
AF:
0.942
Asia WGS
AF:
0.960
AC:
3338
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
4.2
DANN
Benign
0.59
PhyloP100
0.080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6945085; hg19: chr7-146691220; API